Art Mandell - Jun 29, 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
MXCT
Transactions as of
Jun 29, 2022
Transactions value $
$0
Form type
4
Date filed
7/8/2022, 04:02 PM
Previous filing
Aug 11, 2021
Next filing
Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +26.9K $0.00 26.9K Jun 29, 2022 Common Stock 26.9K $4.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date.